The president of Mexico, Andres Manuel Lopez Obrador, has said that the country is sticking to its plan to package domestically the Russian COVID-19 vaccine Sputnik V because health matters are separate from political conflicts, Reuters news agency reported on Wednesday.
In October 2021, state-run vaccine company Birmex had signed an agreement with the Russian Direct Investment Fund (RDIF), which markets Sputnik V, to package the product in Mexico.
The president speaking at a regular news conference said: "We're going to continue with our plan, commitments made are kept", adding, "Health has nothing to do with political conflicts."
Obrador has ruled out imposing economic sanctions against Russia for its invasion of Ukraine, Reuters added.
AKAGERA Medicines completes first cohort in phase 1 SAD/MAD study of AKG-100
Alzinova AB reports positive final Phase 1b results for ALZ-101 in Alzheimer's
Primrose Bio launches Prima RNApols ExTend RNA polymerase for long-template mRNA manufacturing
Merck's CAPVAXIVE approved by EC for pneumococcal disease prevention
Sanofi secures FDA fast track designation for chlamydia vaccine candidate
Anixa Biosciences secures US patent allowance for ovarian cancer vaccine
Valneva to supply IXCHIQ vaccine for chikungunya outbreak in La Réunion
Everest Medicines' EVM14 IND application receives US FDA approval
Clover Biopharmaceuticals' SCB-1019 IND application receives US FDA approval
Centivax partners with Emery Pharma on universal flu vaccine
Avance Biosciences registers with CLIA program
GSK receives approval from US FDA for Penmenvy 5-in-1 meningitis vaccine
hVIVO secures GBP2m contract for final stage of hMPV characterisation study
EU approves CSL and Arcturus Therapeutics' self-amplifying mRNA COVID-19 vaccine
Sanofi and J&J discontinue phase 3 study of E. coli vaccine candidate